Search Results - "Gaynitdinova, Viliya V."

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    N-acetylcysteine for the treatment of COVID-19 among hospitalized patients by Avdeev, Sergey N., Gaynitdinova, Viliya V., Merzhoeva, Zamira M., Berikkhanov, Zelimkhan G.-M.

    Published in The Journal of infection (01-01-2022)
    “…•Low serum levels of H2S in COVID-19 pneumonia are associated with a poor prognosis.•Endogenous H2S production can be increased therapeutically by…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Risk factors for adverse outcomes in elderly patients with asthma and severe COVID-19 at the hospital and early post-hospital stages by Avdeev, S N, Gaynitdinova, V V, Pozdniakova, A A, Vlasenko, A E, Gneusheva, T I, Baytemerova, I V

    Published in Terapevtic̆eskii arhiv (24-02-2023)
    “…Mortality and COVID-19 related factors are thoroughly analyzed. Given the large number of hospitalized patients, the potential short- and long-term COVID-19…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Neutrophilic asthma: current prospects. A review by Viliya V. Gaynitdinova, Zamira M. Merzhoeva, Alena A. Aleksandrova

    Published in Consilium medicum (Online) (01-05-2024)
    “…Asthma, caused by eosinophilic inflammation of the airways, is caused by exposure to allergen, is well treated with glucocorticostroids or monoclonal…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    The effect of immunomodulators on various markers of the acute inflammation phase in patients with mild community-acquired pneumonia by Kostinov, M. P., Gaynitdinova, V. V., Kazharova, S. V., Zorina, V. N., Polischuk, V. B., Vlasenko, A. E.

    Published in Tuberkulëz i bolezni lëgkikh (15-05-2021)
    “…The objective : to study the effect of immunomodulators on markers of the acute inflammation phase in patients with mild community-acquired pneumonia (CAP)…”
    Get full text
    Journal Article